Absci (ABSI) Cash & Current Investments (2020 - 2026)
Absci (ABSI) reported Cash & Current Investments of $125.7 million for Q1 2026, down 6.18% on a YoY basis from $134.0 million in Q1 2025, and down 12.88% sequentially from $144.3 million in Q4 2025.
Absci (ABSI) Cash & Current Investments (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Cash & Current Investments data on file, last reported at $125.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 6.18% year-over-year to $125.7 million; the trailing twelve-month figure through Mar 2026 stood at $125.7 million (down 6.18% YoY), and the FY2025 full-year result was $144.3 million, up 28.35% from the prior year.
- Cash & Current Investments retreated to $125.7 million in Q1 2026, from $144.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $226.0 million in Q1 2022 to a low of $50.0 million in Q2 2022.
- A 5-year average of $136.6 million and a median of $134.0 million in 2025 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments tumbled 49.72% in 2022 and surged 149.16% in 2023, its largest moves.
- Tracing ABSI's Cash & Current Investments over 5 years: stood at $164.4 million in 2022, then sank by 40.61% to $97.7 million in 2023, then gained by 15.12% to $112.4 million in 2024, then increased by 28.35% to $144.3 million in 2025, then retreated by 12.88% to $125.7 million in 2026.
- Business Quant data shows ABSI's Cash & Current Investments at $125.7 million in Q1 2026, $144.3 million in Q4 2025, and $152.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Absci | 1.17 Bn | 1.05 Bn | - | 125.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.71 Mn |
| Dec 31, 2025 | 144.29 Mn |
| Sep 30, 2025 | 152.48 Mn |
| Jun 30, 2025 | 117.46 Mn |
| Mar 31, 2025 | 133.98 Mn |
| Dec 31, 2024 | 112.43 Mn |
| Sep 30, 2024 | 127.07 Mn |
| Jun 30, 2024 | 145.25 Mn |
| Mar 31, 2024 | 161.54 Mn |
| Dec 31, 2023 | 97.66 Mn |
| Sep 30, 2023 | 113.48 Mn |
| Jun 30, 2023 | 124.59 Mn |
| Mar 31, 2023 | 144.26 Mn |
| Dec 31, 2022 | 164.43 Mn |
| Sep 30, 2022 | 181.31 Mn |
| Jun 30, 2022 | 50.00 Mn |
| Mar 31, 2022 | 226.00 Mn |
| Dec 31, 2021 | 252.57 Mn |
| Sep 30, 2021 | 279.26 Mn |
| Jun 30, 2021 | 99.45 Mn |